HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services.  With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

With a coastline of about 3,500 miles, inland sources in Rajasthan and Little Rann of Kutch, and the rock salt mines in Mandi, India have possibilities of attaining a high position in salt production among the salt producing countries of the world. As is known, apart from being an indispensable item of food, salt is an important raw material for the manufacture of several heavy chemicals e.g. soda ash, caustic soda and chlorine.

ABOUT AUTHORS:
Badola Ashutosh,* Nishu Sharma
Shri Guru Ram Rai Institute of Technology & Science ( SGRRITS ),
Dehradun 248001, Uttarakhand , India
*ashutosh.badolam.pharma@gmail.com

ABSTRACT:
Controlled release local drug delivery systems offer advantages compared to systemic dosage forms for periodontitis. The objective of this research was to design and evaluate sustained release dental films containing drug in a non-biodegradable polymer for targeted delivery of the drug. The polymer ethyl cellulose was used in the formulation of dental films. The dental film was then evaluated for various parameters like thickness, folding endurance, and weight variation, and content uniformity, in vitro and in vivo study. Drug release profile of the dental film showed that the film exerted an initial burst release followed by a sustained release of the drug and the drug release was well above the minimum inhibitory concentration throughout the time of study. The release data obtained were subjected for release kinetics study. The study suggested that the non-biodegradable based dental film is a potential local drug delivery device for the treatment of periodontitis.

ABOUT AUTHOR
Kunal Roy
NSHM Group of Institutions Knowledge campus,
Department of Pharmaceutical Analysis & Quality Assurance
Kolkata-700053
kunal.roy17@gmail.com

ABSTRACT:
Counterfeit Culture is a one of the most important and dangerous crime in the world of drugs and its related products  and  explores the dangerous and sometimes deadly world of fake, fraudulent, and faux products. The pharmaceutical  industry has a has history of peddled knock-off  dosage forms, medical devices   but during the last 15 years, it has mushroomed into a global phenomenon.
The range of counterfeit goods now being produced includes pharmaceuticals. The traffic in counterfeit goods is now estimated at a staggering $350 billion representing nearly 10% of all global trade. This illicit and highly profitable criminal enterprise continues to grow unabated and has been linked to organized crime syndicates around the world.

The National Rural Health Mission (NRHM) was launched in April 2005. The NRHM focused especially on 18 states, with poor infrastructure and low public health indicators, namely the eight Empowered Action Group (EAG) states - (Bihar, Jharkhand, Madhya Pradesh, Chhattisgarh, Uttar Pradesh, Uttaranchal, Odisha and Rajasthan), the eight North Eastern States (Assam, Arunachal Pradesh, Manipur, Mizoram, Meghalaya, Nagaland, Sikkim, Tripura) and two other states, namely, Himachal Pradesh and Jammu & Kashmir

The CSIR-CDRI, a premier research institute of the Council of Scientific and Industrial Research (CSIR), invites applications for Ph.D. Programme under Academy of Scientific and Innovative Research (AcSIR) from eligible candidates.

HLL Lifecare Limited (formerly Hindustan Latex Limited) India’s leading manufacturers and marketers of Contraceptive, Health Care and Pharma products is a Mini Ratna Company under the Ministry of Health & Family Welfare, a Govt. of India Enterprise, with Seven manufacturing units and marketing offices throughout the country.

The CSIR-Institute of Himalayan Bioresource Technology. Palampur (CSIR-IHBT) is one of the National Institute under the Council of Scientific & Industrial Research which is an Autonomous Body. It is located on a 250 acres of land with the backdrop of snow-covered peaks of Dhauladhar Range in salubrious climate.

ABOUT AUTHORS:
Tripti Verma*, Keshav Vashistha, Sachin Vispute
B N College of Pharmacy,
Udaipur, Rajasthan
*triptiphsoni22@gmail.com

ABSTRACT:
The review examines the recent  trials of clopidogrel in the treatment of acute coronary syndromes, as well as current cardiac guidelines from several professional societies. As the publication of the landmark study Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE), the clinical benefit of early and intermediate-term use of combined antiplatelet agents--clopidogrel plus aspirin--in non-ST-segment elevation myocardial infarction (NSTEMI) patients became evident. Pretreatment and intermediate-term therapy with clopidogrel in NSTEMI ACS patients undergoing percutaneous coronary intervention (PCI) was further supported by the PCI-CURE trial. Recently, the results of two major trials Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction 28, Clopidogrel and Metoprolol in Myocardial Infarction Trial established the pivotal role of clopidogrel in the other spectrum of ACS-STEMI. Coupled with the results from previous multicentre trials, these two studies provide a guide for the early and long-term use of clopidogrel in the whole spectrum of ACS. A review summarising the results of the recent clinical trials and a discussion on its implications for the clinical management of ACS is presented.Clopidogrel is well established in the treatment of acute coronary syndromes and is ubiquitous in cardiology practice. Landmark studies have established the importance of clopidogrel in the treatment of non-ST and ST elevation myocardial infarction and in percutaneous coronary intervention by reducing death, reinfarction, and adverse cardiac events.

ABOUT AUTHORS:
Miss Apoorva Bhatnagar¹, Dr. S. C. Mahajan^2
1Mahakal institute of pharmaceutical studies,  
²Director at Mahakal Institute of Pharmaceutical Studies,
Ujjain (m.p.)  456010
*apy1590bhtngr@gmail.com

The vision of NMIMS University is to define the 21st century technological and management research. Hence the goal for NMIMS University is to encourage excellence in research and publication activities. Research is a precursor to discovery and innovation.

Aston has been a leading university for graduate employment success for over 25 years. The University is currently ranked 8th overall for graduate employment putting even the likes of Oxford in the shade (2013 Sunday Times University Guide). The University is consistently ranked in the UK's top 40 universities confirming our place amongst the elite.

VIT University will impart futuristic technical education and instil high patterns of discipline through our dedicated staff, who shall set global standards, making our students technologically superior and ethically strong, who in turn shall improve the quality of life of the human race.

Shri Ram Murti Smarak College of Engineering & Technology, Bareilly & Lucknow are the self financed institutes managed and run by SRMS Trust. It is founded in 1996 and the college has demonstrated perennial evidence of merit and quality by achieving a respectable position among all parallel private and govt. colleges of UP Technical University.

JSS Medical Service Trust a sister concern of JSS Mahavidyapeetha, Mysore is running a 1000 bedded hospital in Mysore. To provide the world class medical facility a multi speciality hospital with 1700 beds is constructed at the cost of Rs. 400 crores. Applications are invited from competent, qualified professionals for the following positions.

ABOUT AUTHORS:
Mr. Gunjegaonkar shivshankar M., Mr. T.T. shelke
Dept. of Pharmacology, JSPMs Charak College of pharmacy and research,
Wagholi, Pune, Maharashtra
*gunjeshiv@gmail.com

HLL Lifecare Limited is a Mini Ratna Company of Govt. of India under the Ministry of Health & Family Welfare. HLL, a schedule B Public Sector Enterprise is today a multi product, multi unit organization addressing various public health challenges. The company with five manufacturing units and marketing offices throughout the country is engaged in the manufacturing and marketing of a wide range of contraceptives and healthcare products.

Mylan ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies.